经胃管微创注入肺表面活性物质技术治疗新生儿呼吸窘迫综合征的效果
张佩 夏世文 祝华平 彭斯聪
湖北省妇幼保健院新生儿科,湖北武汉 430010
Effect of minimally invasive injection of pulmonary surfactant through gastric tube in the treatment of neonatal respiratory distress syndrome
ZHANG Pei XIA Shiwen ZHU Huaping PENG Sicong
Department of Neonatology, Hubei Maternal and Child Health Hospital, Hubei Province, Wuhan 430010, China
摘要 目的 探讨经胃管微创注入肺表面活性物质技术在治疗新生儿呼吸窘迫综合征中的效果。 方法 选择2017年5月~2018年5月湖北省妇幼保健院新生儿重症监护室(NICU)收治的胎龄26~34周诊断为呼吸窘迫综合征(RDS)的早产儿40例。按照随机数字表法进行分组,即经胃管微创注入肺表面活性物质(LISA组,20例)和气管插管-肺表面活性物质-拔管(INSURE组,20例),LISA组在经鼻持续气道正压通气(NCPAP)下经直接喉镜直视下向气管内置入5F胃管并缓慢注入肺表面活性物质(PS),INSURE组采用气管插管注入PS,拔管后行NCPAP,观察两组患儿治疗后的呼吸机参数需求的变化情况以及不良反应和并发症的发生率。 结果 LISA组患儿的血氧饱和度(SpO2)下降1例、心动过缓1例、呼吸暂停0例、生后72 h内机械通气1例,明显低于INSURE组的SpO2下降9例、心动过缓8例、呼吸暂停8例、生后72 h内机械通气7例;LISA组6 h后氧浓度下降比例为19%,高于INSURE组的13%,差异有统计学意义(P < 0.05)。两组的再次使用PS、死亡率、气漏、支气管肺发育不良、坏死性小肠结肠炎、早产儿视网膜病、颅内出血等疾病发生率比较,差异无统计学意义(P > 0.05)。 结论 LISA是治疗RDS的一种安全有效的给药方法。
关键词 :
肺表面活性物质 ,
INSURE技术 ,
微创肺表面活性物质给药 ,
呼吸窘迫综合征 ,
新生儿
Abstract :Objective To investigate the effect of minimally invasive injection of pulmonary surfactant through gastric tube in the treatment of neonatal respiratory distress syndrome. Methods Forty preterm infants with respiratory distress syndrome (RDS) diagnosed by neonatal intensive care unit (NICU) in Hubei Maternal and Child Health Hospital from May 2017 to May 2018. According to the random number table method, they were divided into two groups, namely, minimally invasive injection of pulmonary surfactant through gastric tube (LISA group, 20 cases) and tracheal intubation-pulmonary surfactant-extubation (INSURE group, 20 cases). In LISA group, 5F gastric tube was inserted into trachea under direct laryngoscope and pulmonary surfactant (PS) was slowly injected into trachea under nasal continuous positive airway pressure (NCPAP). In INSURE group, PS was injected through tracheal intubation and NCPAP was performed after extubation. The changes of ventilator parameters, adverse reactions incidence of and complications after treatment were observed. Results In LISA group, the decrease of oxygen saturation (SpO2) in 1 case, bradycardia in 1 case, apnea in 0 cases and mechanical ventilation in 72 hours after birth were significantly lower than those in INSURE group SpO2 in 9 cases, bradycardia in 8 cases, apnea in 7 cases; in LISA group, the decrease of oxygen concentration in 6 hours was 19%, higher than that in INSURE group (13%), with significant difference (P < 0.05). There was no significant difference in the incidence of re-use of PS, mortality, air leakage, bronchopulmonary dysplasia, necrotizing enterocolitis, retinopathy of premature infants, intracranial hemorrhage between the two groups (P > 0.05). Conclusion LISA is a safe and effective method for the treatment of RDS.
Key words :
Lung surface active substances
Tracheal intubation-pulmonary surfactant-extubation technology
Minimally invasive pulmonary surfactant administration
Respiratory distress syndrome
Neonatal
基金资助: 湖北省科技厅公益性科技研究项目(2012DCA1 2005)。
作者简介 : 张佩(1986-),女,硕士;研究方向:新生儿疾病。
[1] Hiles M,Culpan AM,Watts C,et al. Neonatal respiratory distress syndrome:Chest X-ray or lung ultrasound? A systematic review [J]. Ultrasound,2017,25(2):80-91.
[2] Crowther CA,Ashwood P,Mcphee AJ,et al. Vaginal progesterone pessaries for pregnant women with a previous preterm birth to prevent neonatal respiratory distress syndrome (the PROGRESS Study):A multicentre,randomised,placebo-controlled trial [J]. PLoS Medicine,2017, 14(9):e1002390.
[3] Canals Candela FJ,Vizcaíno DC,Ferrández Berenguer MJ,et al. Surfactant replacement therapy with a minimally invasive technique:Experience in a tertiary hospital.[J]. Anales De Pediatria,2016,84(2):79-84.
[4] Sweet DG. European consensus guidelines on the management of respiratory distress syndrome-2016 update [J]. Neonatology,2017,111(2):107-125.
[5] Büke B,Destegül E,Akkaya H,et al. Prediction of neonatal respiratory distress syndrome via pulmonary artery Doppler examination [J]. J Matern Fetal Neonatal Med,2017,18(6):1-6.
[6] Kribs A,Roll C,G?pel W,et al. Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants:A Randomized Clinical Trial [J]. JAMA Pediatrics,2015,169(8):723-730.
[7] Varvoutis M,Megan M,Shepherd A,et al. Does Delivery Method Affect Neonatal Outcomes in Diabetic Women? [J]. Obstet Gynecol,2017,129(12):131-316.
[8] Dargaville PA,Aiyappan A,Paoli AGD,et al. Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure [J]. Arch Dis Child Fetal Neonatal Ed,2013,98(2):F122-F126.
[9] Krajewski P,Chudzik A,Strza?覥ko-G?覥oskowska B,et al. Surfactant administration without intubation in preterm infants with respiratory distress syndrome - our experiences [J]. J Matern Fetal Med,2015,28(10):1161-1164.
[10] Bao Y,Zhang G,Wu M,et al. A pilot study of less invasive surfactant administration in very preterm infants in a Chinese tertiary center [J]. Bmc Pediatrics,2015,15(1):21.
[11] More K,Sakhuja P,Shah PS. Minimally invasive surfactant administration in preterm infants:a meta-narrative review [J]. JAMA Pediatrics,2014,168(10):901-908.
[12] Carvalho CG,Silveira RC,Procianoy RS. Ventilator-induced lung injury in preterm infants [J]. Rev Bras Ter Intensiva,2013,25(4):319-326.
[13] Polin RA,Carlo WA,Fetusnewborn CO,et al. Surfactant replacement therapy for preterm and term neonates with respiratory distress [J]. Pediatrics,2014,133(1):156-163.
[14] Laine JE,Bailey KA,Olshan AF,et al. Neonatal Metabolomic Profiles Related to Prenatal Arsenic Exposure [J]. Environ Sci Technol,2017,51(1):625.
[15] Barnes DM,Bates LM. Do racial patterns in psychological distress shed light on the Black-White depression paradox? A systematic review [J]. Soc Psychiatry Psychiatr Epidemiol,2017,52(8):913.
[16] Ramos-Navarro C,Sánchez-Luna M,Zeballos-Sarrato S,et al. Less invasive beractant administration in preterm infants:a pilot study [J]. Clinics,2016,71(3):128-134.
[17] Kort EHMD,Reiss IKM,Simons SHP. Sedation of newborn infants for the INSURE procedure,are we sure? [J]. Biomed Res Int,2013,2013(1):892974.
[18] Gates A,Shave K,Featherstone R,et al. Parent experiences and information needs relating to procedural pain in children:a systematic review protocol [J]. Syst Rev,2017,6(1):109.
[19] Grigg JL,Wolfe LL,Fox KA,et al. Assessing Timing and Causes of Neonatal Lamb Losses in a Bighorn Sheep (Ovis canadensis canadensis) Herd via Use of Vaginal Implant Transmitters [J]. J Wildl Dis,2017,53(3):596-601.
[1]
刘华1 盖迪2 邹丽颖1. 新生儿低血糖的研究及管理现状 [J]. 中国医药导报, 2020, 17(9): 181-184.
[2]
李国曦 江逊 王爱玲▲. 新生儿重症监护病房患儿父母压力源量表的汉化和信效度检验 [J]. 中国医药导报, 2020, 17(8): 56-59.
[3]
李文娟 梅家平 杨勇 叶素芬. NF-κBIA基因多态性与新生儿细菌性脑膜炎易感性相关性分析 [J]. 中国医药导报, 2020, 17(6): 19-22.
[4]
周秀莲1 何好臣2 付晓辉1 高晓巍3. 留置针脐静脉插管在新生儿窒息复苏中的应用 [J]. 中国医药导报, 2020, 17(5): 177-180.
[5]
王巧洪 王婉洪 李俊辉 黄小玲 杨朝容 袁丽珊 黄育丽. 经胸壁B超定位法在新生儿PICC置管中的应用效果 [J]. 中国医药导报, 2020, 17(2): 73-75,80.
[6]
熊伶俐. 高容量血液滤过联合前列地尔治疗新生儿感染性休克合并急性呼吸窘迫综合征的效果 [J]. 中国医药导报, 2020, 17(2): 76-80.
[7]
丁武君1 姚晓燕2 杨戎威1. 纤维支气管镜肺泡灌洗治疗新生儿重症肺炎的临床效果 [J]. 中国医药导报, 2019, 16(9): 94-97.
[8]
刘姣姣1 方平2▲. 川北医学院附属医院新生儿科医院感染现状及其危险因素研究 [J]. 中国医药导报, 2019, 16(8): 92-95.
[9]
武彦秋1 胥冬梅1 周启立1 王志杰1 刘会玲2 董志勇3 刘霞1. 高频振荡通气与西地那非联合治疗新生儿持续性肺动脉高压的临床效果 [J]. 中国医药导报, 2019, 16(8): 88-91.
[10]
陈凤玲 孙东华 杨洪英 郭冬青. 动态血糖监测联合胰岛素泵治疗妊娠期糖尿病对分泌型卷曲相关蛋白5及新生儿预后的影响 [J]. 中国医药导报, 2019, 16(5): 138-141.
[11]
吕朦1 刘秀香1,2. 新生儿肠外营养相关性胆汁淤积的研究进展 [J]. 中国医药导报, 2019, 16(36): 46-49.
[12]
刘弦1,2 杭杲3▲ 胡金绘1 张军1 潘兆军1 武荣1▲. 1135例新生儿呼吸困难的病因、特点和危险因素分析 [J]. 中国医药导报, 2019, 16(36): 100-103.
[13]
杨海娟 许泽辉. 新生儿缺氧性肺动脉高压血清内皮素-1、血管性假血友病因子及Tei指数与肺动脉收缩压的关系 [J]. 中国医药导报, 2019, 16(36): 104-107.
[14]
马延全 于洪志 田磊 葛旭. 外周血NLR对急性呼吸窘迫综合征患者预后的预测价值 [J]. 中国医药导报, 2019, 16(35): 119-122,134.
[15]
索冬梅 周姿杏 刘娟 郭绮棱 李伟玲. 妊娠期糖尿病对新生儿脐带血血气分析的影响 [J]. 中国医药导报, 2019, 16(30): 101-105.